[7] [8] Treatment includes dietary modification, medications to stimulate gastric emptying (including some prokinetic agents), medications to reduce vomiting (including some antiemetics), and surgical approaches
GIP and GLP-1, the two incretin hormones: similarities and differences
Abstract Parkinsons disease (PD) is a chronic, progressive neurological disorder primarily affecting motor control, clinically characterized by resting tremor, bradykinesia, rigidity, and other symptoms that significantly diminish the quality of life
We evaluated initiation of a GLP-1 receptor agonist and the risk of the composite endpoint of all SUDs by subgroups defined according to age, sex, race, BMI categories, HbA 1c levels, and type of GLP-1 receptor agonist
How GLP-1 Medications Work GLP-1, or glucagon-like peptide-1, is a hormone naturally produced in the intestines that plays a role in appetite regulation and blood glucose control
In the first scenario, IBS (K58) and major depression (F33)two comorbid conditions with shared pathophysiological mechanisms 83 were linked by lubiprostone, a drug used to treat constipation, a common manifestation of both diseases 84 (see Fig